Iterum Therapeutics plc (NASDAQ:ITRM) Q1 2024 Earnings Call Transcript May 13, 2024
Iterum Therapeutics plc beats earnings expectations. Reported EPS is $-0.46013, expectations were $-0.57.
Operator: Hello and welcome to the Iterum Therapeutics First Quarter 2024 Financial Results and Business Update. My name is Carla, and I’ll be operating the call today. [Operator Instructions]. I will now hand over to your host, Louise Barrett, Senior Vice President of Legal Affairs to begin. Louise,...
